🚨 Help us choose the host city for the 1st International #ICE_T Conference in 2027! 🌍 🏙️ Top 3 cities announced—your vote decides the winner! 1) Dubai 🇦🇪 2) Barcelona 🇪🇸 3) Istanbul 🇹🇷 🎟️ Vote now for a chance to WIN a trip to the event! Will announce the winning cities

If confirmed - THIS is big. Because a dedicated vectorized antibiotherapy will be possible, it will change the life of many people! (However not all MS might fall in this category)

Evidence Lacking For U.S. AI Dementia Device Approvals Demographic data is often missing from evidence behind FDA-approved AI tools for ADRD, limiting insights into their effectiveness across groups Johns Hopkins Medicine #AI #Alzheimers #dementia hubs.li/Q03zCVy30

New JAMA Insights out! We share practical tips on managing side effects of incretin-based obesity meds to optimize health outcomes Read here 👉 ja.ma/46xZ52W #ObesityCare #GLP1 #UTSW UT Southwestern Medical Center

Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications bmcmedicine.biomedcentral.com/articles/10.11…

A novel paradigm to tackle ASCVD: personalized prevention guided by imaging detected silent atherosclerosis. The REACT initiative: early cure of atherosclerosis through precision prevention academic.oup.com/eurheartj/arti…

Lp(a) as a Prognostic Marker of ASCVD Progression New study with 460k participants showed that: 1️⃣ Median Lp(a) Levels: 1) No Vascular Disease: 19.5 nmol/L 2) Incident PAD: 25.3 nmol/L 3) PAD to MALE: 33.3 nmol/L 4) Incident Carotid Stenosis: 29.5 nmol/L 5) Carotid Stenosis to

50 mg of oral #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. ja.ma/4mq5iSW

🫀 New study using AHA’s Life’s Essential 8 shows US adults still fall short on cardiovascular health (2017–2023 NHANES data). Disparities persist across age, gender & race. Full study: ow.ly/EL6s50WBGcM #CVDPrevention #HeartHealth #LifeEssential8 #PublicHealth

The phase 3 STAR-221 trial will evaluate domvanalimab plus zimberelimab and chemotherapy for the first-line treatment of patients with advanced gastric, GEJ, or esophageal adenocarcinoma. #GastricCancer Read more here: hubs.li/Q03By2xz0

A recent study found that in addition to weight loss, the newer weight loss medications may provide additional ocular benefits over their intended use for weight reduction hubs.li/Q03C61Qw0

MD Anderson is proud to honor more than 100 exceptional faculty members at our 2025 Celebration of Faculty Excellence, recognizing their leadership, innovation and dedication to #EndCancer. Learn about the 2025 award recipients and their impact: spr.ly/6012fsBlC

An overlooked aspect of becoming a scientist is realizing that you have a particular brand; a unique approach, an attraction to a certain kind of problem and a set of connections that you like to make. Uri calls it finding your internal tuning fork. podcasts.apple.com/us/podcast/nig…

The Impact of frailty on the effectiveness of intensive blood pressure control for patients with type 2 diabetes: a secondary analysis of a randomised controlled trial bit.ly/44wzndE

Applications are open for SITC Sparkathon 2026 to be held on March 23–25, 2026, in Tucson, AZ. This year's topic focuses on Next-generation Cellular Therapies, T cell Engagers, and Combinations. Deadline is Nov. 19, 2025 #sparkathon #Immunotherapy sitcancer.org/sparkathon

🔥 Hot Take: Payors Define Clinical Obesity and Medical Necessity—Not the Evidence. You can publish rigorous trials. You can debate diagnostic criteria endlessly. But in practice? No coverage = no care. Payor policy defines what “counts” as obesity for most patients.

Original research: Single-Cell Sequencing: Genomic and Transcriptomic Approaches in Cancer Cell Biology: mdpi.com/1422-0067/26/5… 🧬🖥️🧪 2/2

David Liu, PhD: Performing Chemistry on DNA to Unlock Personalized Gene Editing The inventor of base and #primeediting reveals his approach to engineering molecular machines and translating them into life-changing #therapeutics David R. Liu #DNA hubs.li/Q03DCzLD0

Many learners are more facile with the use of large language models in medicine than their supervisors are. Raja-Elie E. Abdulnour, MD (Raja-Elie Abdulnour), Brian Gin, MD, PhD, and Christy K. Boscardin, PhD, provide an approach to clinical supervision that can mitigate the perils and

Just Published in Global Heart: The Weight of Cardiovascular Diseases: Addressing the Global Cardiovascular Crisis Associated with Obesity | Global Heart /articles/10.5334/gh.1451 World Heart Federation Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 European Society of Cardiology Shelley Zieroth Jagat Narula Prof. Dr. Jose Daniel Piñeiro Francisco Lopez-Jimenez, MD